Ensuring That Drugs Prescribed to Children Are Safe and Effective.

Provides background on the development of P.L. 107-109, the Best Pharmaceuticals for Children Act (BPCA), and P.L. 108-155, the Pediatric Research Equity Act (PREA), both of which allow the FDA to offer financial and regulatory incentives to drug manufacturers for testing their products for pediatri...

Full description

Bibliographic Details

Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2007.
Series:	U.S. Congressional Research.
Subjects:	Medicine > Research. Pharmaceutical industry. Product safety. Electronic books.
Online Access:	Connect to the full text of this electronic book